EmVenio Research Commits to SCRS Global Impact Partner Program
June 6, 2024 – The Society for Clinical Research Sites (SCRS) proudly announces the addition of EmVenio Research to its Global Impact Partner (GIP) Program. EmVenio, a PCM Trials company, is part of the largest independent decentralized clinical trial (DCT) site network and a premier provider of local clinical trial access globally.
With sites located in the United States and the United Kingdom, EmVenio Research is committed to improving access to clinical trials within underrepresented communities and diverse patient populations. EmVenio leverages the combination of mobile sites to enter new communities and research sites in existing community hospitals, to expand the reach of the traditional site network ecosystem. With sites more conveniently located to patients, travel, schedule, and daily life challenges are minimized resulting in improved willingness to participate and remain on studies.
Thad Wolfram, President of EmVenio Research, states, “Becoming a Global Impact Partner with SCRS marks another significant step for EmVenio in raising awareness about the evolution of clinical research sites. We are thrilled to join such a positive and collaborative organization, where mutual growth and learning are encouraged.”
Marcus Maleck, VP of Global Business Partnerships added, “Collaborating with EmVenio through this partnership opens up opportunities for sites, patients and industry to build stronger connections. We admire EmVenio’s commitment to innovation and dedication to increasing accessibility to clinical research around the world, truly making a global impact. SCRS is excited to partner with the EmVenio team and explore how we can collectively work to bring our clinical ecosystem together.”
The SCRS GIP program brings together industry leaders to drive innovation and improve site sustainability, patient engagement, and clinical trial performance. Through this partnership, EmVenio will contribute to the program’s goals of advancing clinical research practices and fostering a more collaborative research environment. To learn more about the Global Impact Partner program, visit scrsprograms.com.
About EmVenio Research
EmVenio Research, a PCM Trials Company, provides a scalable network of clinical trial sites strategically located in underrepresented communities to engage a diverse patient demographic. Our extensive global network comprises highly skilled clinicians, leading principal investigators, and cutting-edge research sites, allowing us to deliver high-quality clinical research services that prioritize reducing the burden on patient participation. Visit emvenio.com to learn more.
About the Society for Clinical Research Sites (SCRS)
The Society for Clinical Research Sites (SCRS) is the leading advocacy organization dedicated to unifying the voice of the global clinical research site community. Representing more than 11,000 research sites in 54 countries, SCRS facilitates industry collaborations and conversations dedicated to site-focused advocacy, education, mentorship, and connection. SCRS is an active and influential champion for sites in industry initiatives to ensure that the perspective of sites is heard and valued. Learn more and get involved at myscrs.org. Our voice. Our community. Your success.
